ETR:2B70 Holdings Information

ETR:2B70 is an equity ETF with a total of 266 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 7.67%, Amgen at 7.60%, Gilead Sciences at 7.57%, Regeneron Pharmaceuticals at 6.15%, and Alnylam Pharmaceuticals at 4.78%.

Total Holdings

266

Top 10 Percentage

46.88%

Asset Class

Equity

ETF Category

Health Care

Assets

528.81M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	7.67%	93,110
2	AMGN	Amgen Inc.	7.60%	142,822
3	GILD	Gilead Sciences, Inc.	7.57%	373,897
4	REGN	Regeneron Pharmaceuticals, Inc.	6.15%	62,579
5	ALNY	Alnylam Pharmaceuticals, Inc.	4.78%	67,569
6	AZN	AstraZeneca PLC	4.63%	351,367
7	ARGX	argenx SE	2.27%	18,791
8	SMMT	Summit Therapeutics Inc.	2.10%	442,266
9	INSM	Insmed Incorporated	2.10%	108,498
10	BIIB	Biogen Inc.	2.01%	87,279
11	ILMN	Illumina, Inc.	1.75%	94,314
12	RPRX	Royalty Pharma plc	1.66%	250,236
13	INCY	Incyte Corporation	1.55%	114,953
14	SNY	Sanofi	1.37%	167,093
15	NBIX	Neurocrine Biosciences, Inc.	1.36%	58,772
16	ONC	BeOne Medicines Ltd.	1.34%	24,665
17	UTHR	United Therapeutics Corporation	1.33%	26,787
18	MEDP	Medpace Holdings, Inc.	1.31%	17,069
19	MRNA	Moderna, Inc.	1.22%	229,671
20	BMRN	BioMarin Pharmaceutical Inc.	1.19%	113,888
21	BNTX	BioNTech SE	1.15%	59,330
22	ASND	Ascendis Pharma A/S	1.13%	36,031
23	VTRS	Viatris Inc.	1.10%	697,003
24	EXEL	Exelixis, Inc.	1.06%	161,951
25	TEM	Tempus AI, Inc.	1.02%	99,811

As of Jul 31, 2025

Showing 25 of 266

Subscribe to see the full list